#eccmid2023 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #eccmid2023, aggregated by home.social.
-
RT VACCELERATE Consortium 🇪🇺🇺🇦
#VACCELERATE: A European network for the development of #COVID19 vaccine #clinicaltrials and beyond: Interview with @KerstinAlbus at #ECCMID2023.
Interview and filming by @touchINFECTDIS.
https://www.youtube.com/watch?v=Pmlvmzi6NbA https://t.co/to1dgdm42F🐦🔗: https://n.respublicae.eu/vaccelerate_eu/status/1671455343669280769
-
🆕 Episode of #Breakpoints
In this special LIVE podcast episode, Drs. Jason Pogue and Erin McCreary present from Making a Difference in Infectious Diseases (MAD-ID) and give a rundown of everything from some #ECCMID2023 late breakers to published RCTs to stewardship-focused papers.
Have no fear: this episode is a COVID-free zone 😎
Listen now: https://sidp.pinecast.co/ -
RT @ECDC_EU: ECDC is present at #ECCMID2023! Visit our booth B4-27 for a meet-and-greet with our experts:
➡️Aikaterini Mougkou (@KMougkou), Monday, 10:30–10:45
➡️Eeva Broberg (@broberg_e), Monday, 10:45–11:00
➡️Lucia Pastore Celentano, Monday, 15:45–16:00
➡️Vivian Leung, Tuesday, 10:45–11:00🐦🔗: https://n.respublicae.eu/EMA_News/status/1647892201769189376
-
RT @ECDC_EU: Today ECDC Director Andrea Ammon participated in a session on measuring the changing threat of COVID-19 at #ECCMID2023.
Dr Ammon provided a European perspective on how the pandemic was assessed and how we can improve for future threats.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1647892040385003522
-
RT @vaccelerate_eu: Our #VACCELERATE topics for the #ECCMID2023 final spurt: #ResearchNurses, #MAK5, #VolunteerRegistry #BeTheMissingPiece.
We are looking forward to a lively exchange and an exciting last day!
@Fiona_Cologne @JuliaNacov @SalmantonGarcia🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1647984774978338820
-
RT @vaccelerate_eu: For your day planning at #ECCMID2023 in Copenhagen tomorrow 👇.
We would be very happy to talk to you about #VACCELERATE, #COVID19, #clinicaltrials, our #VolunteerRegistry and the #SiteNetwork.
#BeTheMissingPiece
@VaccelerateCY @SalmantonGarcia @JuliaNacov🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1647860729859416065
-
RT @vaccelerate_eu: Visiting #ECCMID2023 in Copenhagen, April 15th -18th?
Don't miss out on visiting us in the Poster Arena on 17th and 18th - Very excited to meet you in Denmark and looking forward to informing you about #VACCELERATE.
@EU_HaDEA🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1646797179783184385
-
Aikaterini Mougkou, Expert Antimicrobial Resistance and Healthcare Associated Infections, holding a meet-and-greet session at the ECDC info stand at #ECCMID2023
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647946965991190528
-
Today ECDC Director Andrea Ammon participated in a session on measuring the changing threat of COVID-19 at #ECCMID2023.
Dr Ammon provided a European perspective on how the pandemic was assessed and how we can improve for future threats.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647886860281151490
-
ECDC is present at #ECCMID2023! Visit our booth B4-27 for a meet-and-greet with our experts:
➡️Aikaterini Mougkou (@KMougkou), Monday, 10:30–10:45
➡️Eeva Broberg (@broberg_e), Monday, 10:45–11:00
➡️Lucia Pastore Celentano, Monday, 15:45–16:00
➡️Vivian Leung, Tuesday, 10:45–11:00🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647607484025126920
-
Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".
Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻
Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏
-
Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".
Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻
Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏
-
@mackayim2022 very fair point.
I tried, but hard enough to live tweet to also live toot at the same time!
At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023 -
@mackayim2022 very fair point.
I tried, but hard enough to live tweet to also live toot at the same time!
At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023 -
#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists -
#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists -
At #ECCMID2023 & interested in whether IL-6 is important in #TB?
If so, pop by & visit my poster P1063 12:00-13:30
Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1 -
At #ECCMID2023 & interested in whether IL-6 is important in #TB?
If so, pop by & visit my poster P1063 12:00-13:30
Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1 -
Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)Exciting field #ECCMID2023
-
Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)Exciting field #ECCMID2023
-
One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen
-
One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen
-
Net immunosuppreve effect in organ transplant recipients.
Important concept in susceptibility to infections #ECCMID2023
-
Net immunosuppreve effect in organ transplant recipients.
Important concept in susceptibility to infections #ECCMID2023
-
Inclusion of fosfomycin in prophylaxis guideline (single centre data), big reduction in total antibiotic use
#urology #prophylaxis #UTI #ECCMID2023 -
Inclusion of fosfomycin in prophylaxis guideline (single centre data), big reduction in total antibiotic use
#urology #prophylaxis #UTI #ECCMID2023 -
Importance discordances in the indication and duration of antibiotic prophylaxis for urological surgery #AMS #AMR #urology #prophylaxis #ECCMID2023
-
Importance discordances in the indication and duration of antibiotic prophylaxis for urological surgery #AMS #AMR #urology #prophylaxis #ECCMID2023
-
Mendelian randomisation of IL-6 receptor alleles
👉reduced IL-6 classic signalling ➡️ reduced risk of sepsis & sepsis death (as seen in #COVID19
Paper here: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004174
-
Mendelian randomisation of IL-6 receptor alleles
👉reduced IL-6 classic signalling ➡️ reduced risk of sepsis & sepsis death (as seen in #COVID19
Paper here: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004174
-
SAFO trial
:Right pointing backhand index:MSSA bacteraemia
:Right pointing backhand index:Cloxacillin vs Cloxacillin + Fosfomycin
Protocol previously published here: https://bmjopen.bmj.com/content/11/8/e051208.long…:⭐:Comparable treatment success at day 7:⭐:
Faster bacteraemia clearance at day 3 with fosfomycin.
-
SAFO trial
:Right pointing backhand index:MSSA bacteraemia
:Right pointing backhand index:Cloxacillin vs Cloxacillin + Fosfomycin
Protocol previously published here: https://bmjopen.bmj.com/content/11/8/e051208.long…:⭐:Comparable treatment success at day 7:⭐:
Faster bacteraemia clearance at day 3 with fosfomycin.
-
Clear illustration of challenges harmonising clinical data in defining #sepsis subgroups across different centres. #ECCMID2023
-
Clear illustration of challenges harmonising clinical data in defining #sepsis subgroups across different centres. #ECCMID2023
-
#ECCMID2023 is finally here! We have an exceptional congress lined up for you over the next four days inlcuding impressive Keynote lectures and tons of educational and exciting sessions. You can access it all and learn more here: http://ow.ly/5kzS50NI49F
-
#ECCMID2023 is finally here! We have an exceptional congress lined up for you over the next four days inlcuding impressive Keynote lectures and tons of educational and exciting sessions. You can access it all and learn more here: http://ow.ly/5kzS50NI49F
-
Book your own meeting box at #ECCMID2023 in the exhibition hall! The offer is free of charge. There are two tiny conditions: registration and meeting must be on the same day and no meeting should last longer than one hour.
http://ow.ly/rmA050Nxl6i -
The mega-topics of digitalisation and machine learning raise a thousand questions. #ECCMID2023 keynote speaker Adrian Egli talks about promises and challenges. Hall A, April 15, 2.45–3.45 p.m. CET.
http://ow.ly/eu7n50MLtJG -
The mega-topics of digitalisation and machine learning raise a thousand questions. #ECCMID2023 keynote speaker Adrian Egli talks about promises and challenges. Hall A, April 15, 2.45–3.45 p.m. CET.
http://ow.ly/eu7n50MLtJG -
Slept through #EarlyBird registration? You don’t have to be sad – you can still secure your registration for #ECCMID2023 to get access to all live content as it happens. See you there! http://ow.ly/zIQ150MLt5S
-
Slept through #EarlyBird registration? You don’t have to be sad – you can still secure your registration for #ECCMID2023 to get access to all live content as it happens. See you there! http://ow.ly/zIQ150MLt5S
-
But here’s a small reminder! You can submit your novel and unpublished data in the late-breaking abstract submission for #ECCMID2023. Be sure to submit your abstract before 15 February! http://ow.ly/f1Wj50MLsHY
-
But here’s a small reminder! You can submit your novel and unpublished data in the late-breaking abstract submission for #ECCMID2023. Be sure to submit your abstract before 15 February! http://ow.ly/f1Wj50MLsHY
-
-
-
Prof Gunnar Kahlmeter has received the #ESCMID Excellence Award 2023! Admittedly, for the "Father of EUCAST", it’s been something like a home match. Come around to experience his lecture on “Antimicrobial susceptibility testing” during #ECCMID2023.
http://ow.ly/HeNe50MGOaE -
Prof Gunnar Kahlmeter has received the #ESCMID Excellence Award 2023! Admittedly, for the "Father of EUCAST", it’s been something like a home match. Come around to experience his lecture on “Antimicrobial susceptibility testing” during #ECCMID2023.
http://ow.ly/HeNe50MGOaE -
Good news: the #ECCMID Online Platform is open! Take a look at the programme and find out more about the highlights of #ECCMID2023. If you are already registered, start right away and filter out your personal highlights. Or register now at http://ow.ly/mPAW50MBbwc.
-
Good news: the #ECCMID Online Platform is open! Take a look at the programme and find out more about the highlights of #ECCMID2023. If you are already registered, start right away and filter out your personal highlights. Or register now at http://ow.ly/mPAW50MBbwc.
-
We are so excited! Carlos del Rio, MD & leading authority in the field of #GlobalHealth and #Epidemiology, will be joining the upcoming #ECCMID2023 for a #KeynoteScientificInterview on “Structural determinants of health”.
#Copenhagen (15–18 April 2023)
http://ow.ly/7R7450Mw8Ex -
We are so excited! Carlos del Rio, MD & leading authority in the field of #GlobalHealth and #Epidemiology, will be joining the upcoming #ECCMID2023 for a #KeynoteScientificInterview on “Structural determinants of health”.
#Copenhagen (15–18 April 2023)
http://ow.ly/7R7450Mw8Ex -
ICOHAR 2023 will take place in Copenhagen just after #ECCMID2023 (18-20 April). The programme features sessions exploring AMR surveillance, transmission, stewardship, MDR bacteria and more. Abstract submission is open now until January 30. Don't miss out!
-
ICOHAR 2023 will take place in Copenhagen just after #ECCMID2023 (18-20 April). The programme features sessions exploring AMR surveillance, transmission, stewardship, MDR bacteria and more. Abstract submission is open now until January 30. Don't miss out!
-
Don't forget to submit your original artwork to be included in the #ECCMID2023 art gallery! We are offering prizes for five lucky submitters including even registration to #ECCMID! Learn more and submit before the deadline on 31 December 2022.
-
Don't forget to submit your original artwork to be included in the #ECCMID2023 art gallery! We are offering prizes for five lucky submitters including even registration to #ECCMID! Learn more and submit before the deadline on 31 December 2022.
-
Thank you to all abstract submitters for #ECCMID2023. With nearly 6,000 abstracts from >120 countries, our community members showed their willingness to return to ECCMID to network, exchange and present exciting new results of their research!
-
Thank you to all abstract submitters for #ECCMID2023. With nearly 6,000 abstracts from >120 countries, our community members showed their willingness to return to ECCMID to network, exchange and present exciting new results of their research!
-
Applications for the ESCMID Förderverein Grant are closing! This new grant for #ECCMID2023 will support attendees from LMICs by providing registration and covering all travel and accommodation fees. Applications close 15 December 2022! Learn more: http://ow.ly/7S3450LTgII
-
These are the last hours of #ECCMID2023 abstract submission. The submission platform will close today at 16:00 CET and there will be no other extensions possible. Be a part of the #ECCMID programme, submit your research now!
-
The deadline for #ECCMID2023 abstract submission has been extended until 2 December 2022 at 16:00 CET
Be sure to take advantage of the extra time to put the finishing touches on and get in your last pieces of original research!
http://ow.ly/paiU50LR5v0